MD3940F1 - Metoda de tratament al paraliziei plexului brahial - Google Patents

Metoda de tratament al paraliziei plexului brahial

Info

Publication number
MD3940F1
MD3940F1 MDA20080101A MD20080101A MD3940F1 MD 3940 F1 MD3940 F1 MD 3940F1 MD A20080101 A MDA20080101 A MD A20080101A MD 20080101 A MD20080101 A MD 20080101A MD 3940 F1 MD3940 F1 MD 3940F1
Authority
MD
Moldova
Prior art keywords
days
over
homaccord
day
biologically active
Prior art date
Application number
MDA20080101A
Other languages
English (en)
Other versions
MD3940G2 (ro
Inventor
Svetlana Hadjiu
Original Assignee
Svetlana Hadjiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Svetlana Hadjiu filed Critical Svetlana Hadjiu
Priority to MDA20080101A priority Critical patent/MD3940G2/ro
Publication of MD3940F1 publication Critical patent/MD3940F1/ro
Publication of MD3940G2 publication Critical patent/MD3940G2/ro

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Inventia se refera la medicina, neurologie, pediatrie si este destinata tratamentului paraliziilor plexului brahial la nou-nascuti si sugari. Metoda, conform inventiei, consta in aceea ca se administreaza per os Bryaconeel si Nervoheel cate 1/4…1/2 pastila de 3 ori pe zi timp de 1 luna; Cinnamomum-Homaccord N, Lymphomyosot si Galium-Heel N de 3 ori pe zi cate 3…5 picaturi timp de 1 luna; subcutanat Traumeel S cate 0,4…0,8 ml zilnic in primele 3 zile, apoi peste 1 zi, Cerebrum Compositum N cate 0,4…0,8 ml peste 3 zile, Gelsemium-Homaccord cate 0,3…0,5 ml peste 2 zile, Ferrum-Homaccord cate 0,3…0,5 ml peste 3 zile, Circulo-Injeel cate 0,3…0,6 ml de 2 ori pe saptamana, la o serie de tratament de 7…10 injectii, de asemenea Coenzyme compositum si Ubichinon Compositum cate 0,3…0,5 ml o data pe saptamana, la o serie de tratament de 2…4 injectii. Totodata, preparatele mentionate se administreaza in urmatoarele puncte biologic active: T14; V11; IG 2-8, 12,15; VB21; G 5-12, 14-15; P5,9; C3-8; MC3-9; TR3-10; AP37,41,55,63,64,65,66. In fiecare punct biologic activ se introduce un singur preparat medicamentos mentionat cate 0,1…0,3 ml, care se administreaza in 3…5 puncte, totodata in fiecare zi se selecteaza diferite puncte biologic active.
MDA20080101A 2008-04-07 2008-04-07 Metodă de tratament al paraliziei plexului brahial MD3940G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20080101A MD3940G2 (ro) 2008-04-07 2008-04-07 Metodă de tratament al paraliziei plexului brahial

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20080101A MD3940G2 (ro) 2008-04-07 2008-04-07 Metodă de tratament al paraliziei plexului brahial

Publications (2)

Publication Number Publication Date
MD3940F1 true MD3940F1 (ro) 2009-07-31
MD3940G2 MD3940G2 (ro) 2010-02-28

Family

ID=40941130

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20080101A MD3940G2 (ro) 2008-04-07 2008-04-07 Metodă de tratament al paraliziei plexului brahial

Country Status (1)

Country Link
MD (1) MD3940G2 (ro)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA59569A (uk) * 2002-08-08 2003-09-15 В'ячеслав Євгенович Сотниченко Спосіб лікування хворих з паралічем плечового сплетіння та пристрій для його здійснення

Also Published As

Publication number Publication date
MD3940G2 (ro) 2010-02-28

Similar Documents

Publication Publication Date Title
EA201591529A1 (ru) Лечение детского дефицита гормона роста человеческими аналогами гормона роста
JP2016514132A5 (ro)
WO2016109823A8 (en) Treatment of pediatric growth hormone deficiency with human growth hormone analogues
Chen et al. Effects of icariin on orthodontic tooth movement in rats
MD3940F1 (ro) Metoda de tratament al paraliziei plexului brahial
MD424Y (ro) Metodă de tratament al afecţiunilor parodonţiului
MD3803F1 (ro) Metoda de tratament al hiperchineziilor lacopii
MD3359F1 (ro) Metoda de tratament conservativ al herniilor de disc
JOP20170044B1 (ar) تركيبة صيدلانية تشتمل على hgh ناتج عن عودة الارتباط الجيني لعلاج نقص هرمون النمو
MD3927F1 (ro) Metoda de tratament al paraliziei faciale
MD3906F1 (ro) Metoda de tratament al enurezisului nevrotic la copii
Kumari et al. Recent advancement in topical drug delivery for psoriasis: clinical pertinence and potential market
Braun et al. AB0743 Secukinumab Improves Multiple Parameters of Disease Activity in Subjects with Active Ankylosing Spondylitis Through 52 Weeks of Subcutaneous Therapy: Data From the Phase 3 Measure 2 Study
Gligorov et al. SAFEHER: a study of assisted-and self-administered subcutaneous trastuzumab (H-SC) as adjuvant therapy in patients with early HER2-positive breast cancer (EBC)
RAWAL et al. Efficacy Of Acitretin In Management Of Acrodermatitis Continua Of Hallopeau And Consequence Of Medication Non-Adherence In Ach: A Case Report
Armstrong et al. Bimekizumab clinical efficacy in important body regions and health-related quality of life in patients with plaque psoriasis: Data from four phase 3/3b comparator-controlled trial periods
BS A COMPREHENSIVE REVIEW ON SEBASTIANIACHAMAELEA (L). MUELL. ARG
Schlessinger et al. 53083 Efficacy and safety of a novel formulation liquid botulinum toxin, RelabotulinumtoxinA, when used for combination treatment of glabellar and lateral canthal lines
Stein et al. 49328 Effects of Titanium Dioxide Nanoparticles in Skin Wound Healing
CN1843373A (zh) 生发液
BR112022006748A2 (pt) Métodos para tratar um indivíduo que sofre de ganho de peso e em risco de sofrer ganho de peso induzidos por antipsicótico
NZ773583A (en) Methods of treating psoriasis
MOON High-Dose Vitamin D May Raise Fracture Risk
KR20230090187A (ko) 알츠하이머병을 동반한 혈관성 치매를 치료하는 약제학적 복합제제
GR1006093B (el) Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ (ursolic acid) για την θεραπεια ψωριασης

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees